MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2

被引:20
作者
Cui, Shao-Qian [1 ]
Wang, Huan [1 ]
机构
[1] China Med Univ, Dept Orthoped, Shengjing Hosp, Shenyang 110004, Liaoning Provin, Peoples R China
关键词
MicroRNA-144; Ezrin; Osteosarcoma; Target protein; Methylthiazol tetrazolium assay; DOWN-REGULATION; PRIMARY TUMOR; EZRIN; EXPRESSION; PROGNOSIS; METASTASIS; ACTIVATION; GROWTH;
D O I
10.1007/s13277-015-3396-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study is aimed to investigate the role of microRNA-144 (miR-144) in osteosarcoma cell line F5M2 proliferation, apoptosis, invasion, and metastasis. Between 2007 and 2014, 66 cases of osteosarcoma samples in the corresponding adjacent normal tissue samples were selected from surgical resection or biopsy in the Department of Orthopedics, Shengjing Hospital, China Medical University. MiR-144 levels and Ezrin messenger RNA (mRNA) levels in osteosarcoma and the adjacent bone tissues were detected, and clinical and pathological features were analyzed. Exogenous miR-144 was transfected into human osteosarcoma cell lines at two different concentrations (low and high), and the expression levels of miR-144 and Ezrin protein between highly metastatic osteosarcoma cells and lowly metastatic osteosarcoma cells were compared. Real-time polymerase chain reaction (RT-PCR) and Western blot were used for detecting the expression levels of miR-144 or Ezrin protein, respectively. Cell proliferation was measured by methylthiazol tetrazolium (MTT) assay. Cell invasion and migration was evaluated by Transwell assays. Finally, flow cytometry was employed to determine the cell apoptosis. MiR-144 expression in osteosarcoma tissue was significantly lower than that in the surrounding normal bone tissue (P < 0.001), while Ezrin mRNA expression in osteosarcoma tissue was significantly higher than that in the surrounding normal bone tissue (P < 0.001); correlation analysis showed a significant negative correlation between miR-144 and Ezrin mRNA levels (r = 0.982, P < 0.001). MiR-144 and Ezrin mRNA expressions were significantly related with cell metastasis (P < 0.05) but were not related with other clinical factors such as gender, age, tumor location, tumor size, Enneking staging, and Dahlin's histological classification. The results of RT-PCR showed that the expression level of miR-144 in osteosarcoma cells increased after transfected with exogenous miR-144 mimics, and this increase positively correlated with the transfection concentration of miR-144 mimics. Furthermore, Western blotting revealed a significant and dose-dependent decrease in Ezrin protein levels in F5M2 cells transfected with miR-144. MTT and Transwell assays showed that the invasion and metastasis of F5M2 cells was significantly decreased following exogenous overexpression of miR-144. Our study supports the view that the miR-144 may regulate Ezrin protein expression by inhibiting the invasion and metastasis of osteosarcoma cells.
引用
收藏
页码:6949 / 6958
页数:10
相关论文
共 43 条
[1]  
An Jiyuan, 2010, Journal of Bioinformatics and Computational Biology, V8, P99, DOI 10.1142/S0219720010004574
[2]   Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts [J].
Andersson, Gustav ;
Wennersten, Christoffer ;
Gaber, Alexander ;
Boman, Karolina ;
Nodin, Bjorn ;
Uhlen, Mathias ;
Segersten, Ulrika ;
Malmstrom, Per-Uno ;
Jirstrom, Karin .
BMC UROLOGY, 2014, 14
[3]   Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression [J].
Athanasopoulou, Afrodite ;
Aroukatos, Panagiotis ;
Nakas, Dimitrios ;
Repanti, Maria ;
Papadaki, Helen ;
Bravou, Vasiliki .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (06) :836-842
[4]   Recent advances in osteosarcoma [J].
Botter, Sander M. ;
Neri, Dario ;
Fuchs, Bruno .
CURRENT OPINION IN PHARMACOLOGY, 2014, 16 :15-23
[5]   Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells [J].
Bulut, G. ;
Hong, S-H ;
Chen, K. ;
Beauchamp, E. M. ;
Rahim, S. ;
Kosturko, G. W. ;
Glasgow, E. ;
Dakshanamurthy, S. ;
Lee, H-S ;
Daar, I. ;
Toretsky, J. A. ;
Khanna, C. ;
Ueren, A. .
ONCOGENE, 2012, 31 (03) :269-281
[6]   Bone Deposition, Bone Resorption, and Osteosarcoma [J].
Caminada Toledo, Silvia Regina ;
Oliveira, Indhira Dias ;
Okamoto, Oswaldo Keith ;
Zago, Marco Antonio ;
de Seixas Alves, Maria Teresa ;
Garcia Filho, Reynaldo Jesus ;
Pacheco Donado Macedo, Carla Renata ;
Petrilli, Antonio Sergio .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2010, 28 (09) :1142-1148
[7]   Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers [J].
Creighton, Chad J. ;
Fountain, Michael D. ;
Yu, Zhifeng ;
Nagaraja, Ankur K. ;
Zhu, Huifeng ;
Khan, Mahjabeen ;
Olokpa, Emuejevoke ;
Zariff, Azam ;
Gunaratne, Preethi H. ;
Matzuk, Martin M. ;
Anderson, Matthew L. .
CANCER RESEARCH, 2010, 70 (05) :1906-1915
[8]   MicroRNA Profiles Discriminate among Colon Cancer Metastasis [J].
Drusco, Alessandra ;
Nuovo, Gerard J. ;
Zanesi, Nicola ;
Di Leva, Gianpiero ;
Pichiorri, Flavia ;
Volinia, Stefano ;
Fernandez, Cecilia ;
Antenucci, Anna ;
Costinean, Stefan ;
Bottoni, Arianna ;
Rosito, Immacolata A. ;
Liu, Chang-Gong ;
Burch, Aaron ;
Acunzo, Mario ;
Pekarsky, Yuri ;
Alder, Hansjuerg ;
Ciardi, Antonio ;
Croce, Carlo M. .
PLOS ONE, 2014, 9 (06)
[9]   Experimental validation and complexity of miRNA-mRNA target interaction during zebrafish primitive erythropoiesis [J].
Du, Ting-Ting ;
Fu, Yan-Fang ;
Dong, Mei ;
Wang, Lei ;
Fan, Hong-Bo ;
Chen, Yi ;
Jin, Yi ;
Chen, Sai-Juan ;
Chen, Zhu ;
Deng, Min ;
Huang, Qiu-Hua ;
Liu, Ting Xi .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 381 (04) :688-693
[10]   MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration [J].
Duan, Zhenfeng ;
Choy, Edwin ;
Harmon, David ;
Liu, Xianzhe ;
Susa, Michiro ;
Mankin, Henry ;
Hornicek, Francis .
MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) :1337-1345